Salk Institute

Technologies Available for Licensing


Inventors: Wylie Vale, Joan Vaughan, Cynthia Donaldson, Kathy Lewis, Paul Sawchenko, Jean Rivier, Marilyn Perrin
Potential Uses: A native mammalian peptide with potent hypotensive activity used as a therapeutic or target

The invention relates to Urocortin, a native mammalian peptide generally related to Urotensin I and Corticotropin Releasing Factor (CRF). Urocortin or analogs thereof not only are potent hypotensive agents but they have additional pharmacological and physiological properties over and beyond those of heretofore known CRFs. Pharmaceutical compositions of Urocortin can be used to lower blood pressure or increase coronary flow, decrease swelling and inflammation, improve memory and learning performance, and elevate mood. The invention also relates to competitive binding assays which are particularly useful for screening candidates for new drugs.

Salk No: S96012
Patent Status: U.S. Patent No. 6,214,797 issued April 10, 2001
Publications: Nature 378: 287-292 (1995)
Endocrinology 137: 2167-2170 (1996)
Science 273: 1561-1564 (1996)
License Terms: Exclusive, Partially Exclusive, Nonexclusive license negotiable
Contact: Michelle Booden, Ph.D., Director of Licensing, 858.453.4100 x1612,

Get Involved

Sign up for our email newsletter

Fill out my online form.
Salk Institute for Biological Studies
Street: 10010 N Torrey Pines Rd
City: La Jolla, CA 92037
Phone: 858.453.4100
Charity Navigator Rating
  • Salk Twitter
  • Salk LinkedIn
  • Salk Facebook
  • Salk Instagram
  • Salk Google+
  • Salk YouTube
  • Salk RSS Feed
© Copyright 2015 Salk Institute for Biological Studies | Privacy Policy About Scientists & Research News & Media Events Support